Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
The return on assets (ROA) is N/A as of Tuesday, October 6, 2026.
RETURN ON ASSETS (ROA)
N/A
Obsidian Therapeutics Inc.
Market Cap
$14.53M
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.37M
Return on Assets (ROA)
-15.57%
TTM Avg
-20.73%
3Y Avg
-20.84%
5Y Avg
-41.87%
Market Cap
$14.03M
Return on Assets (ROA)
-32.53%
TTM Avg
-31.07%
3Y Avg
-30.77%
5Y Avg
-29.89%
Market Cap
$15.10M
Return on Assets (ROA)
-201.89%
TTM Avg
-113.65%
3Y Avg
-83.24%
5Y Avg
-72.72%
Market Cap
$15.15M
Return on Assets (ROA)
-41.18%
TTM Avg
-60.23%
3Y Avg
-53.11%
5Y Avg
-40.22%
Market Cap
$13.83M
Return on Assets (ROA)
-123.23%
TTM Avg
-153.35%
3Y Avg
-205.77%
5Y Avg
-166.29%
Market Cap
$13.71M
Return on Assets (ROA)
-85.85%
TTM Avg
-102.78%
3Y Avg
-95.22%
5Y Avg
-76.09%
Market Cap
$15.58M
Return on Assets (ROA)
-213.77%
TTM Avg
-110.51%
3Y Avg
-93.41%
5Y Avg
-68.22%
Market Cap
$13.44M
Return on Assets (ROA)
-27.12%
TTM Avg
-32.94%
3Y Avg
-35.27%
5Y Avg
-29.16%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Obsidian Therapeutics Inc. (OBX) | $14.53M | N/A | N/A | N/A | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.37M | -15.57% | -20.73% | -20.84% | -41.87% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.03M | -32.53% | -31.07% | -30.77% | -29.89% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.10M | -201.89% | -113.65% | -83.24% | -72.72% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.15M | -41.18% | -60.23% | -53.11% | -40.22% |
| Vyome Holdings, Inc. (HIND)vs › | $13.83M | -123.23% | -153.35% | -205.77% | -166.29% |
| IN8bio, Inc. (INAB)vs › | $13.71M | -85.85% | -102.78% | -95.22% | -76.09% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.58M | -213.77% | -110.51% | -93.41% | -68.22% |
| Optimi Health Corp. (OPTH)vs › | $13.44M | -27.12% | -32.94% | -35.27% | -29.16% |
| Passage Bio, Inc. (PASG)vs › | $13.30M | -143.44% | -68.17% | -65.00% | -57.74% |
ROA
N/A
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
